PCM
MJN

Prelude Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Prelude Capital Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-108,489
Closed -$9.66M – 2033
2017
Q1 		$9.66M Buy
+108,489
New +$8.92M 0.92% 14
2016
Q4 		– Sell
-187
Closed -$15K – 1958
2016
Q3 		$15K Buy
+187
New +$15.9K ﹤0.01% 1383
2016
Q2 		– Sell
-2,610
Closed -$222K – 1864
2016
Q1 		$222K Buy
+2,610
New +$194K 0.03% 520
2014
Q4 		– Sell
-200
Closed -$19K – 2324
2014
Q3 		$19K Buy
+200
New +$18.9K ﹤0.01% 1742
2014
Q2 		– Sell
-3,500
Closed -$291K – 2323
2014
Q1 		$291K Sell
3,500
-1,000
-22% -$81.1K 0.04% 604
2013
Q4 		$377K Buy
+4,500
New +$366K 0.06% 444

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Prelude Capital Management's MJN Position: Q2 2017 in Review

Prelude Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 108,489 shares — an estimated $9.66M sold.

Prelude Capital Management first reported a position in MJN in Q4 2013 and held it in 6 quarters. The position peaked at $9.66M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Prelude Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Prelude Capital Management sold 108,489 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $9.66M.
  • Prelude Capital Management first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 6 quarters.
  • Prelude Capital Management's Mead Johnson Nutrition Company position peaked at $9.66M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.